Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

This publication has 23 references indexed in Scilit:

• Characteristics and Outcome of Chinese Patients with Both Antineutrophil Cytoplasmic Antibody and Antiglomerular Basement Membrane Antibodies
  Nephron Clinical Practice, 2007
• A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
  Nature Biotechnology, 2007
• Scientific and regulatory considerations on the immunogenicity of biologics
  Trends in Biotechnology, 2006
• Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies
  Journal of Pharmaceutical and Biomedical Analysis, 2005
• Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
  Clinical and Vaccine Immunology, 2003
• Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin
  Diabetes, 1996
• Clinical correlations of Anti-Gm1 antibodies in amyotrophic lateral sclerosis and neuropathies
  Muscle & Nerve, 1991
• Detection of Antibodies Directed against a Liver-Specific Membrane Lipoprotein in Patients with Acute and Chronic Active Hepatitis
  New England Journal of Medicine, 1978
• Epstein‐barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer
  Journal of Surgical Oncology, 1978
• HUMAN IMMUNITY TO THE MENINGOCOCCUS
  The Journal of Experimental Medicine, 1969